• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection.

作者信息

Mancon A, Rizzo A, Mileto D, Grosso S, Foschi A, Cutrera M, Capetti A, Faggion I, Anselmo A, Monte A, Fillo S, Rizzardini G, Gismondo M R, Micheli V

机构信息

Laboratory of Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco - University of Milan, Milan, Italy.

Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.

出版信息

Emerg Microbes Infect. 2022 Dec;11(1):786-789. doi: 10.1080/22221751.2022.2045877.

DOI:10.1080/22221751.2022.2045877
PMID:35209808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8920372/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d28/8920372/7f9e9ea95edf/TEMI_A_2045877_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d28/8920372/7f9e9ea95edf/TEMI_A_2045877_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d28/8920372/7f9e9ea95edf/TEMI_A_2045877_F0001_OC.jpg

相似文献

1
Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection.对一名患有长期新冠病毒2型（SARS-CoV-2）感染的免疫功能低下患者的病毒免疫学评估。
Emerg Microbes Infect. 2022 Dec;11(1):786-789. doi: 10.1080/22221751.2022.2045877.
2
Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.两名免疫功能低下患者的 SARS-CoV-2 病毒持续排出：病例报告
BMC Infect Dis. 2021 Aug 3;21(1):743. doi: 10.1186/s12879-021-06429-5.
3
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.在一项前瞻性、开放性标签临床试验中，评估了 mRNA BNT162b2 疫苗在五组免疫功能低下患者和健康对照者中的安全性和有效性。
EBioMedicine. 2021 Dec;74:103705. doi: 10.1016/j.ebiom.2021.103705. Epub 2021 Nov 30.
4
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者：体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
5
T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease.免疫功能低下的炎症性肠病患者接种 SARS-CoV-2 疫苗后的 T 细胞反应。
J Crohns Colitis. 2022 Feb 23;16(2):251-258. doi: 10.1093/ecco-jcc/jjab147.
6
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.免疫功能低下患者中SARS-CoV-2的进化与免疫逃逸
N Engl J Med. 2022 Jun 23;386(25):2436-2438. doi: 10.1056/NEJMc2202861. Epub 2022 Jun 8.
7
National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.全国范围内对 114 万 NHS 员工进行的 SARS-CoV-2 血清学检测的横断面调查：NHS 员工与区域社区血清转化率的比较。
BMJ Open. 2021 Jul 13;11(7):e049703. doi: 10.1136/bmjopen-2021-049703.
8
Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection.SARS-CoV-2 感染后门诊患者体液和细胞免疫应答的长期过程。
Front Public Health. 2021 Sep 27;9:732787. doi: 10.3389/fpubh.2021.732787. eCollection 2021.
9
Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center.免疫功能低下患者血清 SARS-CoV-2 阳性率和疾病进程：一家儿科四级保健中心的研究
J Pediatric Infect Dis Soc. 2021 Apr 30;10(4):426-431. doi: 10.1093/jpids/piaa123.
10
Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.通过对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）IgM和IgG血清阳性进行纵向监测以检测新型冠状病毒肺炎（COVID-19）
J Appl Lab Med. 2020 Sep 1;5(5):908-920. doi: 10.1093/jalm/jfaa079.

引用本文的文献

1
Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient.在一名免疫功能低下患者的血液中持续检测和测序严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
J Med Virol. 2023 Jan;95(1):e28381. doi: 10.1002/jmv.28381.
2
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency.识别继发性免疫缺陷患者中新兴的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体的标志物。
Front Microbiol. 2022 Jul 1;13:933983. doi: 10.3389/fmicb.2022.933983. eCollection 2022.

本文引用的文献

1
Where did 'weird' Omicron come from?“诡异”的奥密克戎毒株源自何处？
Science. 2021 Dec 3;374(6572):1179. doi: 10.1126/science.acx9738. Epub 2021 Dec 2.
2
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.SARS-CoV-2 mRNA 疫苗 BNT162b2 引发一致的跨变体体液和细胞反应。
Emerg Microbes Infect. 2021 Dec;10(1):2235-2243. doi: 10.1080/22221751.2021.2004866.
3
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.
COVID-19 患者体内 SARS-CoV-2 的宿主内进化是免疫逃逸变异株的来源。
Nat Commun. 2021 Nov 4;12(1):6405. doi: 10.1038/s41467-021-26602-3.
4
Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response.评估 QuantiFERON SARS-CoV-2 检测法以评估低和高体液免疫反应个体中 BNT162b2 mRNA COVID-19 疫苗的细胞免疫原性。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5148-5149. doi: 10.1080/21645515.2021.1991710. Epub 2021 Oct 29.
5
SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.美国加利福尼亚州 HIV/AIDS 患者体内的 SARS-CoV-2 中和耐药突变。
Emerg Infect Dis. 2021;27(10):2720-2723. doi: 10.3201/eid2710.211461. Epub 2021 Jul 23.
6
Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents.BNT162b2信使核糖核酸2019冠状病毒病疫苗在疗养院居民中的体液免疫原性和细胞免疫原性
Clin Infect Dis. 2021 Dec 6;73(11):2145-2147. doi: 10.1093/cid/ciab300.
7
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性：系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
8
Mixed cytomegalovirus genotypes in HIV-positive mothers show compartmentalization and distinct patterns of transmission to infants.HIV 阳性母亲的混合巨细胞病毒基因型显示出分隔和向婴儿传播的不同模式。
Elife. 2020 Dec 31;9:e63199. doi: 10.7554/eLife.63199.
9
A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge?一例超长病毒脱落期病例：细胞培养物能否成为推动 COVID-19 患者出院的诊断工具？
Int J Infect Dis. 2021 Mar;104:631-633. doi: 10.1016/j.ijid.2020.11.161. Epub 2020 Nov 20.
10
Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis.通过全基因组准种分析评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在上呼吸道和下呼吸道中的分区复制
Microorganisms. 2020 Aug 26;8(9):1302. doi: 10.3390/microorganisms8091302.